5.221 makale bulundu

Erken Dönem Parkinson Hastalığının Diferansiyel Tanısı için Midbrain Energy Homeostasis Biyobelirteç: A <sup>1</sup>H ve <sup>31</sup>P MRI Çalışması.

Midbrain Energy Homeostasis Biomarker for Differential Diagnosis of Early-Stage Parkinson Disease: A <sup>1</sup>H and <sup>31</sup>P MRI Study.

Yu Q, Zhang Y, Huang P, Li Y, Liu P, Jin Z, Wang X, Zhang B, Weng J, Wu P, Haacke EM, Wiegers EC, Wijnen JP, Klomp DWJ, Haller S, Chen S, Yan F, He N.

Radiology · 2026-04-01

DOI: 10.1148/radiol.251533PMID: 41944724

Parkinson Hastalığının MPTP Fare Modeline Bağlı Beyin Değişiklikleri Difüzyon Kurtluğu Görüntüleme ve Manyetik Rezonans Spektroskopisi ile Ortaya Çıktı.

Brain Alterations Linked to the MPTP Mouse Model of Parkinson's Disease Uncovered by Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy.

Modi A, Maria S, Ruda-Kucerova J, Drazanova E, Harastova-Pavlova I, Sejnoha Minsterova A, Kovacovicova K, Havas D, Rektorova I, Outeiro TF, Khairnar A.

CNS Neurosci Ther · 2026-04-01

DOI: 10.1002/cns.70846PMID: 42007507

[Clinical practice guideline for integrated PET/MRI in Parkinson's disease (2026 edition)].

Chinese Society of Medical Imaging Technology, Chinese Society of Radiology, Chinese Society of Nuclear Medicine, Beijing Society of Nuclear Medicine, Beijing Society of Radiology.

Zhonghua Yi Xue Za Zhi · 2026-04-01

DOI: 10.3760/cma.j.cn112137-20251222-03386PMID: 42049519

Sistemik hastalıklarda beyin-vücut etkileşimleri: görüntüleme perspektifinden bir anket.

Brain-body interactions in systemic diseases: a survey from an imaging perspective.

Li F, Zhao S, Liang Z, Xu Z, Bai S, Zhou W, Zheng Q, Yan W, Wang L, Sun K, Zhang H, Shen D.

MedScience · 2026-04-01

DOI: 10.1007/s11684-026-1229-8PMID: 42189396

Presinaptik dopaminerjik görüntüleme, alfa-sinükleinopati sürekliliğinde bir nörodejenerasyon evreleyici biyobelirteç olarak.

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.

Eur J Nucl Med Mol Imaging · 2026-04-01

DOI: 10.1007/s00259-026-07834-1PMID: 41917515

AI-Driven Multimodal Analysis of Neuroimaging and Speech Data for Diagnosis of Alzheimer's, Parkinson's, and Epilepsy.

Verma P, Dhamdhere T, Shaikh A, Saxena H, Saha S, Bapat S.

Biotechnol Appl Biochem · 2026-04-01

DOI: 10.1002/bab.70169PMID: 41918394

Parkinson hastalığının moleküler nörogörüntülenmesi: sinaptik yoğunluk, dopaminerjik ve serotonerjik sistemlerle motor ve motor olmayan semptomların birleşmesi.

Molecular neuroimaging of Parkinson's disease: association of motor and non-motor symptoms with synaptic density, dopaminergic and serotonergic systems.

Schubert JJ, Rota S, Batzu L, Zinzalias P, Barwick N, Lee S, Veronese M, Reith AD, Parker CA, Williams SCR.

Neuroimage Rep · 2026-03-31

DOI: 10.1016/j.ynirp.2026.100337PMID: 41994471

[ 18 F]-Flortaucipir PET/MRI Supports a 4R Tauopathy Phenotype in Corticobasal Degeneration.

Chen M, Franceschi AM.

Clin Nucl Med · 2026-03-31

DOI: 10.1097/rlu.0000000000006461PMID: 41949407

Yarı Otomatik Nöromelanin-Sensitif MR, Orta Teşhis Performansı ile Erken Parkinson Hastalığında Substantia Nigra Hacmi Azaltılmasını Gösteriyor.

Semi-Automated Neuromelanin-Sensitive MRI Reveals Substantia Nigra Volume Reduction in Early Parkinson's Disease with Moderate Diagnostic Performance.

Silovs A, Skuburs GK, Zdanovskis N, Sevcenko A, Mednieks J, Naudins E, Bartusevica S, Umbrasko S, Zarina L, Zelge L, Pastare AA, Steinberga J, Skilters J, Pinna B, Platkajis A.

Diagnostics (Basel) · 2026-03-30

DOI: 10.3390/diagnostics16071046PMID: 41975757

The Deep Learning Revolution in Neuroimaging: Insights from a Bibliometric Analysis (2014-2024).

Chaki J, Deshpande G.

Neuroinformatics · 2026-03-27

DOI: 10.1007/s12021-026-09775-4PMID: 41894064

Limbic free-water alterations as neuroimaging biomarkers for predicting phenoconversion in prodromal Parkinson's disease.

Chen A, Deng F, Yu S, Kuang Z, Yang C, Khong PL, Huang J, Wei X.

Parkinsonism Relat Disord · 2026-03-27

DOI: 10.1016/j.parkreldis.2026.108296PMID: 42013782

[Molecular Imaging of Tau and α-Synuclein Pathologies: Technical Advances, Challenges, and Opportunities].

Gnörich JS, Franzmeier N, Brendel M.

Fortschr Neurol Psychiatr · 2026-03-27

DOI: 10.1055/a-2823-2465PMID: 41895301